Pharmaceutical Working Group Go back »

The Pharmaceutical Working Group is comprised of 38 foreign pharmaceutical manufacturing companies. All members are committed to cooperating closely with Chinese healthcare stakeholders, in order to establish a competitive healthcare system which serves all Chinese patients. As such, the Working Group strongly welcomes the initiatives made for the long-term, which will substantially benefit both Chinese patients and the Chinese economy. The technology transferred from Europe further demonstrates the commitment these companies make in supporting China’s goal to become an innovative society by 2020.

  • Chair: Ms Ye Li, Merck
  • Vice Chair: Ms Yingrong Du, Abbott; Ms Daphne Richet-Cooper, Sanofi
  • Next meeting: 2019-04-24

Related Lobby Actions View all »

2019-04-09

Comments to Ministry of Science and Technology (MOST)' s on Safety Management Regulations for Biotechnology Research and Development (Call for Comments)

Read more

2019-03-26

Comments on NHSA's 2019 National Reimbursement Drug List Adjustment Work Plan

Read more

Related EURObiz articles

You are currently not a member of this Working Group.

Join this Working Group

Chamber contact
Helei Fu
Helei Fu

Beijing

+86 (021) - 6385 2023 ext. 124
Click to email

Helei Fu
Helei Fu

Shanghai

+86 (021) - 6385 2023 ext. 124
Click to email

Quick jump to:

Back to overview